Evidence map›Paper›PMID 18972208›Full record

ArticleDigestive diseases and sciences2009

The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis.

Cemal Nuri Ercin, Zeki Yesilova, Ahmet Korkmaz, Ayhan Ozcan, Cagatay Oktenli, Ahmet Uygun

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. The role of hyperbaric oxygen therapy in the treatment of radiation lesions.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cemal Nuri ErcinDivision of Internal Medicine, Department of Gastroenterology, Gulhane School of Medicine, Etlik, Ankara, Turkey. cnercin@hotmail.com
Zeki Yesilova
Ahmet Korkmaz
Ayhan Ozcan
Cagatay Oktenli
Ahmet Uygun
Gülhane Askerî Tıp Akademisi · TRGATA Haydarpaşa Eğitim Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimOur aim was to investigate the effectiveness of aminoguanidine (AMG), an inducible nitric oxide synthase inhibitor, and hyperbaric oxygen (HBO) treatment in an experimental colitis model.

methodsWe induced colitis in rats. In the control group, we applied 2 ml serum physiologic intraperitoneally for 7 days. In the HBO group, 100% oxygen at 2.4 atm pressure was applied for 7 days. In the AMG group, 100 mg/kg AMG was applied intraperitoneally for 7 days. In the HBO + AMG group, HBO and AMG were applied, respectively. At the end of 7 days, rats were sacrificed and the distal 10 cm part of colon was examined macro- and microscopically.

resultsSeverity of colitis and NO activities were reduced by AMG, HBO, and HBO + AMG application. There was histologically significant improvement, especially in the HBO + AMG group.

conclusionsBoth HBO and AMG were significantly effective in preventing weight loss, reducing NO activities, and severity of colitis, when comparing HBO and AMG separately.

Indexed as

Acetic AcidAnimalsColitisCombined Modality TherapyDisease Models, AnimalFemaleGuanidinesHyperbaric OxygenationNitric OxideNitric Oxide Synthase Type IIRatsRats, Sprague-DawleySeverity of Illness IndexTreatment OutcomeAcetic AcidGuanidinesNitric OxideNitric Oxide Synthase Type IIpimagedine

Identifiers

PMID18972208
OpenAlexW2016544784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.